- Revenues in the first quarter grown by 14% to € 3.9 m (prev. year € 3.4 m)
- Earnings before interest and taxes (EBIT) increased by € 0.6 m to € 1.2 m, 31 % EBIT margin
- Financial result declined by just under € 1.0 m to € -0.9 m
Bremen, May 24, 2016 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, today announced its figures for the first quarter in 2016.
Sales in the first quarter of 2016 came to € 3,876 k, up 14 % on the first quarter of 2015 (prev. year € 3,408 k). The sales growth of € 468 k is largely due to maintenance revenues which have increased since mid-2015. Sales in the new license business improved by a satisfactory 9 % to € 1,701 k, while sales in the maintenance business increased by 27 % to € 1,889 k, now accounting for 49 % of total sales. Sales in the Digital Mammography segment were up by 16 % to € 3,145 k (prev. year: € 2,721 k), while sales in the Other Diagnostics segment improved slightly by 6 % to € 731 k (prev. year: € 687 k).
Operating costs in the first quarter of 2016 fell slightly due to a slight drop in staff costs and on the back of other operating expenses. Staff costs decreased by 2 % in the first quarter. Other operating expenses in the first quarter declined to € 529 k compared to the previous year’s quarter (prev. year: € 549 k).
After depreciation and amortization of € 448 k (down 21 % year on year primarily due to lower scheduled amortization of capitalized development costs), EBIT (earnings before interest and taxes) amounted to € 1,183 k in the period under review (up a significant 118 % on the previous year’s figure of € 542 k) and an EBIT margin of 31 % (prev. year: 16 %).
The financial result deteriorated by € -997 k year on year to € -859 k. Negative effects from the US dollar exchange rate combined with a higher share of liquidity in US dollars were largely responsible for this.
Due to the fiscal unity which became effective as of January 1, 2016, the tax result amounted to € 0 k (prev. year: expense of € 42 k).
After-tax earnings consequently fell by € 315 k to € 324 k, which is equivalent to undiluted earnings per share of € 0.18 (prev. year: € 0.37).